Osteoradionecrosis of the mandible in conjunction with mastoiditis is an extremely rare occurrence following irradiation of salivary gland malignancy in the orofacial region.
INTRODUCTION:
Osteoradionecrosis (ORN) is a condition of non-vital bone in a site of radiation injury which was first described by Marx in 1983 as hypovascularity, hypocellularity, and local tissue hypoxia. 1 . ORN can be spontaneous, but it most commonly results from tissue injury.
The absence of reserve reparative capacity is a result of the prior radiation injury. Even apparently innocuous forms of trauma such as denture-related injury, ulcers, or tooth extraction can overwhelm the reparative capacity of the radiation-injured bone.
ORN is more common in the mandible but rare in the temporal bone. 2 The first case of osteoradionecrosis involving the temporal bone was reported by Block in a patient with syringobulba in 1952. 3 Co-occurrence of ORN in mandible as well as temporal bone have rarely been reported.
It is more common in the mandible than in the maxilla, probably because of the richer vascular supply to the maxilla and the fact that the mandible is more frequently irradiated. 4 We hereby report a rare instance of ORN involving the mandible and mastoid in a patient after radiotherapy for muco-epidermoid carcinoma of the parotid gland.
CASE REPORT:
A 38-year-old female patient reported to the Department of Oral Medicine and
Radiology with the complaint of pain in the right back region of the lower jaw since 15 days.
Pain was insidious in onset, continuous in nature and radiated to the right ear. Patient had restricted mouth opening. Patient also reported of intermittent discharge from the right ear since past 5 years, which was colourless initially and purulent later. Patient had visited otolaryngologist for the ear discharge on numerous occasions, medications were prescribed but no reductions in symptoms were observed. Patient presented with history of surgery and radiotherapy in the same region for a nodular growth five years prior to the date of reporting.
The discharge summary revealed the treatment modalities were carried out for a low-grade mucoepidermoid carcinoma. The patient reported of dryness of the mouth after surgery and radiotherapy. No histories of dizziness, tinnitus, vertigo or fainting episodes were reported.
On clinical examination bilateral temperomandibular joint movements were restricted with only 5 mm mouth opening. Right submandibular lymph node was palpable, enlarged, soft in consistency, tender and freely movable measuring about 3 cms in diameter ( Figure 1 ).
Extra-oral examination revealed diffuse purplish black discoloration of the overlying skin in the pre-auricular, post-auricular region and angle of the mandible of the right side.
The skin over the angle of the mandible had desquamated shiny appearance. A surgical scar extended from the right ear lobe to the base of the mandible. Purulent discharge was noticed in relation to the right external auditory meatus. There was diffuse areas of hyper and hypo pigmentation within the ear [ Figure 2 ]. On palpation, the area was hard in consistency. The masseter muscle and the sternocleidomastoid muscle were fibrosed.
Intra-oral examination could not be performed due to restricted mouth opening. Chronic otomastoiditis may result as a complication arising from osteoradionecrosis of the temporal bone as in our case. This may further result in hearing loss, gross tissue extrusion, more severe complications including meningitis, facial palsy, intradural and/or extradural abscesses, pneumocephalus, lateral sinus thrombosis, fistula formation into the parotid gland or temporal mandibular joint, and other cranial neuropathies. 5 In our case the right temporomandibular joint was involved.
In our patient, the disease was relatively diffuse involving mostly the mastoid, the mandible including the condyle and masticator space, but not the cranial base. The patient presented with an exceptionally rare complication of osteoradionecrosis of the temporal bone, secondary to radiotherapy for parotid tumor. On consultation with a otolaryngologist, tympanic membrane perforation noticed. However, considering the lack of otologic complaints before radiotherapy, the perforation was thought to have been caused by radionecrosis and/or subsequent infection. Osteoradionecrosis and mastoiditis after radiotherapy Page 7
The incidence of temporal bone ORN is higher after mastoidectomy for facial nerve identification or resection in patients undergoing parotidectomy with postoperative radiotherapy. 6 The management of osteoradionecrosis in the temporal bone is controversial. In the localized type, conservative treatment with frequent aural cleansing and topical antibiotics is often administered. 7 Oversew of the ear canal with mastoid obliteration should be considered in this subgroup of patients to avoid this long-term complication of radiotherapy used in the treatment of malignant parotid tumors. 6 The risk for osteoradionecrosis and infection can be minimized by removing all poorly supported teeth, allowing sufficient time for the extraction wounds to heal before beginning radiation therapy, and adjusting dentures to minimize the risk for denture sores. 4 Prior to beginning radiation therapy, all patients should undergo a thorough dental evaluation, including full mouth radiographs, dental and periodontal diagnosis, and prognosis for each tooth. It is generally accepted that meticulous preventive dental treatment should be planned for patients receiving radiotherapy to the head and neck region. 8 In addition to oral hygiene maintenance with routine dental follow-up, non-surgical or 'conservative' therapy includes nutritional support, topical medicaments, systemic antibiotics and hyperbaric oxygen. 8 In 1983, Marx proposed a staging protocol (which was modified subsequently) combining surgery and hyperbaric oxygen for more aggressive treatment of ORN. He was able to achieve complete resolution in all 58 cases. 9 The management of patients afflicted with ORN of the jaws usually consists of a combination of different modalities and will be determined by factors such as the size of the defect, the signs and symptoms of the patient, the cosmetic and functional derangement consequent to the complication. 8 For an unresponding case or the diffuse type of osteoradionecrosis, surgical management is indicated. Surgical management of osteoradionecrosis has met with limited success because of the difficulty of accurate assessment of the viability of non-necrotic bone. Failure to resect all non-viable bone results in recurrence of a necrotic focus. 10 Since such expertise was not available in our case, the patient had to be referred to higher centre for further management. after resection of the diseased tissue rather than in a staged fashion. 11 For advanced ORN of the mandible, radical resection followed by reconstruction using free flap provides a reliable means of obtaining good wound healing with acceptable aesthetic and functional results. 12 Despite diligent radical treatment, suspicion of recurrent cancer always persists.
Extensive osteoradionecrosis with a multiple discharging fistula, a large area of exposed necrotic bone, or a coexistent fracture should be treated primarily with radical sequestrectomy and microvascular free flap reconstruction. Surgery plays a major role in controlling osteoradionecrosis along with adjuvant hyperbaric oxygen therapy. caused by intra-/interfraction motion, and by allowing for adaptive replanning to changes that occur in the tumor or patient during long courses of radiotherapy. In doing so, these changes are leading to improvements in the therapeutic ratio, where doses are increased at diseasedsites and minimized at normal tissues. 14 We must also keep in mind that no single imaging modality can provide an entire picture of tumour profiling. Anatomical and functional imaging fusion is essential. Future studies should help determine whether incorporating these and other imaging modalities will improve our ability to cure head and neck cancer and/or reduce the morbidity of the treatment.
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CONCLUSION:
Data available regarding osteoradionecrosis are insufficient to assist clinicians faced with the management and in counselling patients as to the anticipated outcome of therapy.
Efforts should be made to monitor patients who have been enrolled in such treatment protocols for long periods of time to evaluate the quality of life and late complications of therapy.
This report stresses the importance of educating health care professionals, especially dentists and oral surgeons, of a rare but important side effect of radiation therapy in the head and neck area. It is especially useful in bringing to light the importance of dental evaluation prior to and after radiation therapy to improve patient treatment outcome. 
